Drugs / DUOVENT HFA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03910985 | Apr 2019 → Dec 2021 | chronic obstructive pulmonary disease | Centre Hospitalier Universitaire UCLouvain Namur | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DUOVENT HFA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03910985 ↗ |
| Route | Inhaled | “4 puffs of DUOVENT HFA, using an inhalation chamber” NCT03910985 ↗ |